Medicine & Life Sciences
Leishmania infantum
100%
Leishmaniasis
82%
Canidae
63%
Parasites
61%
Leishmania
47%
Dogs
44%
Visceral Leishmaniasis
38%
Infections
23%
Portugal
21%
Meglumine Antimoniate
16%
T-Lymphocytes
14%
Zoonoses
14%
Cutaneous Leishmaniasis
13%
Trifluralin
12%
Theileria annulata
12%
Parasitic Diseases
12%
Macrophages
11%
Neutrophils
11%
Cytokines
11%
Liver
11%
Cellular Immunity
10%
Plasmodium chabaudi
9%
Extracellular Vesicles
9%
ursolic acid
9%
Allopurinol
8%
Innate Immunity
8%
Lymph Nodes
8%
Animals
8%
Skin
8%
Interleukin-12
8%
Kupffer Cells
8%
Interleukin-10
7%
Bone Marrow
7%
Immunomodulation
7%
In Vitro Techniques
7%
Antibodies
7%
Spleen
6%
Liposomes
6%
Cattle
6%
Antibody Formation
6%
Vaccines
6%
falcipain
6%
Gene Expression
5%
T-Lymphocyte Subsets
5%
miltefosine
5%
Agglutination Tests
5%
Interleukin-4
5%
Psychodidae
5%
Leishmania guyanensis
5%
Babesiosis
5%
Agriculture & Biology
Leishmania infantum
75%
leishmaniasis
69%
dogs
53%
parasites
37%
Leishmania
30%
promastigotes
26%
infection
23%
visceral leishmaniasis
23%
amastigotes
21%
Portugal
18%
T-lymphocytes
16%
immune response
16%
allopurinol
14%
cytokines
14%
macrophages
11%
neutrophils
11%
Kupffer cells
11%
Theileria annulata
10%
lymph nodes
10%
antibodies
9%
bone marrow
9%
interleukin-10
8%
therapeutics
8%
innate immunity
8%
immunomodulation
8%
ursolic acid
8%
interleukin-12
8%
Leishmania donovani
8%
blood
7%
relapse
7%
mice
7%
interleukin-4
7%
drug therapy
6%
cells
6%
Leishmania shawi
6%
pathogenicity
6%
Plasmodium chabaudi chabaudi
6%
humoral immunity
6%
hepatocytes
6%
immune system
6%
African trypanosomiasis
5%
Leishmania guyanensis
5%
Plasmodium chabaudi
5%
skin (animal)
5%
cell-mediated immunity
5%
animals
5%
immunophenotyping
5%
cutaneous leishmaniasis
5%
antibody formation
5%
trifluralin
5%